Targeting organ-specific mitochondrial dysfunction to improve biological aging.
Autor: | Madreiter-Sokolowski CT; Division of Molecular Biology and Biochemistry, Medical University of Graz, BioTechMed-Graz, Austria. Electronic address: corina.madreiter@medunigraz.at., Hiden U; Department of Obstetrics and Gynecology, Research Unit of Early Life Determinants, Medical University of Graz, Austria., Krstic J; Division of Cell Biology, Histology and Embryology, Medical University of Graz, BioTechMed-Graz, Austria., Panzitt K; Diagnostic and Research Institute of Pathology, Medical University of Graz, Austria., Wagner M; Division of Gastroenterology and Hepatology, Medical University of Graz, Austria., Enzinger C; Department of Neurology, Medical University of Graz, Austria., Khalil M; Department of Neurology, Medical University of Graz, Austria., Abdellatif M; Division of Cardiology, Medical University of Graz, BioTechMed-Graz, Austria., Malle E; Division of Molecular Biology and Biochemistry, Medical University of Graz, BioTechMed-Graz, Austria., Madl T; Division of Medicinal Chemistry, Medical University of Graz, BioTechMed-Graz, Austria., Osto E; Division of Physiology and Pathophysiology, Medical University of Graz., Schosserer M; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Austria; Christian Doppler Laboratory for Skin Multimodal Imaging of Aging and Senescence, Austria., Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Austria., Olschewski A; Department of Anesthesiology and Intensive Care Medicine, LBI for Lung Vascular Research, Medical University of Graz, Austria. Electronic address: andrea.olschewski@medunigraz.at. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pharmacology & therapeutics [Pharmacol Ther] 2024 Oct; Vol. 262, pp. 108710. Date of Electronic Publication: 2024 Aug 22. |
DOI: | 10.1016/j.pharmthera.2024.108710 |
Abstrakt: | In an aging society, unveiling new anti-aging strategies to prevent and combat aging-related diseases is of utmost importance. Mitochondria are the primary ATP production sites and key regulators of programmed cell death. Consequently, these highly dynamic organelles play a central role in maintaining tissue function, and mitochondrial dysfunction is a pivotal factor in the progressive age-related decline in cellular homeostasis and organ function. The current review examines recent advances in understanding the interplay between mitochondrial dysfunction and organ-specific aging. Thereby, we dissect molecular mechanisms underlying mitochondrial impairment associated with the deterioration of organ function, exploring the role of mitochondrial DNA, reactive oxygen species homeostasis, metabolic activity, damage-associated molecular patterns, biogenesis, turnover, and dynamics. We also highlight emerging therapeutic strategies in preclinical and clinical tests that are supposed to rejuvenate mitochondrial function, such as antioxidants, mitochondrial biogenesis stimulators, and modulators of mitochondrial turnover and dynamics. Furthermore, we discuss potential benefits and challenges associated with the use of these interventions, emphasizing the need for organ-specific approaches given the unique mitochondrial characteristics of different tissues. In conclusion, this review highlights the therapeutic potential of addressing mitochondrial dysfunction to mitigate organ-specific aging, focusing on the skin, liver, lung, brain, skeletal muscle, and lung, as well as on the reproductive, immune, and cardiovascular systems. Based on a comprehensive understanding of the multifaceted roles of mitochondria, innovative therapeutic strategies may be developed and optimized to combat biological aging and promote healthy aging across diverse organ systems. Competing Interests: Declaration of competing interest The authors declare no conflict of interest. (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |